Troy Ignelzi, CFO at Rapport Therapeutics, Inc., holds 15.50K shares in Rapport Therapeutics, Inc. (Ticker: RAPP), holds ― shares in Harmony Biosciences Holdings (Ticker: HRMY), holds 0.00 shares in Esperion (Ticker: ESPR). Most recently, Troy Ignelzi Bought ― shares of Rapport Therapeutics, Inc. on Oct 21, 2026 for an estimated value of $143.55K.
Troy Ignelzi latest transaction was an Informative Buy of $143.55K.
What was Troy Ignelzi's most profitable transaction?
Troy Ignelzi’s most profitable transaction was an Informative Buy of RAPP stock on March 13, 2025. The return on the trade was 177.80%.
What is Troy Ignelzi's role in Rapport Therapeutics, Inc.?
Troy Ignelzi's role in Rapport Therapeutics, Inc. is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.